Syndax Pharmaceuticals Inc Cash Flow Reinvestment Rate
Syndax Pharmaceuticals Inc cash flow reinvestment rate. Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Reinvestment Rate of 0.60x as of December 2021, reinvesting $59.96 Million (capex $129.00K plus investments $-59.83 Million) from operating cash flow of $100.71 Million. Explore how well can Syndax Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Syndax Pharmaceuticals Inc (2021–2021)
Cash flow reinvestment rate of Syndax Pharmaceuticals Inc from 2021 to 2021. Historical reinvestment intensity for Syndax Pharmaceuticals Inc across 1 annual periods. Explore capital reinvestment ratio of Syndax Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Syndax Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2021–2021)
Syndax Pharmaceuticals Inc cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for Syndax Pharmaceuticals Inc. For the full cash flow conversion analysis, see Syndax Pharmaceuticals Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.40x | $40.87 Million | $29.13 Million | $129.00K | — |